Tag: UroGen Pharma

UroGen Pharma has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $120,000,000.00 in Post-IPO Equity.

UroGen Pharma has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $120,000,000.00 in Post-IPO Equity.

According to filings with the U.S. Securities and Exchange Commission, UroGen Pharma is raising $120,000,000.00 in new funding. About UroGen Pharma: UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions…

Read More Read More

UroGen Pharma has filed a notice of an exempt offering of securities to raise $120 Million in New Equity Investment.

UroGen Pharma has filed a notice of an exempt offering of securities to raise $120 Million in New Equity Investment.

According to filings with the U.S. Securities and Exchange Commission, UroGen Pharma is raising $120,000,000.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Don Kim played a key role…

Read More Read More